Search
Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity
Abstract
Fungal pathogens are considered as serious factors for deadly diseases and are a case of medical concern. Invasive fungal infections also complicate the clinical course of COVID-19, leading to a significant increase in mortality. Furthermore, fungal strains' multidrug resistance has increased the demand for antifungals with a different mechanism of action. The present study aimed to identify antifungal compounds targeting yeast topoisomerase II (yTOPOII) derived from well-known human topoisomerase II (hTOPOII) poisons C-1305 and C-1311. Two sets of derivatives: triazoloacridinones (IKE1-8) and imidazoacridinones (IKE9-14) were synthetized and evaluated with a specific emphasis on the molecular mechanism of action. Our results indicated that their effectiveness as enzyme inhibitors was not solely due to intercalation ability but also as a result of influence on catalytic activity by the formation of covalent complexes between plasmid DNA and yTOPOII. Lysine conjunction increased the strength of the compound's interaction with DNA and improved penetration into the fungal cells. Triazoloacridinone derivatives in contrast to starting compound C-1305 exhibited moderate antifungal activity and at least twice lower cytotoxicity. Importantly, compounds (IKE5-8) were not substrates for multidrug ABC transporters whereas a derivative conjugated with lysine (IKE7), showed the ability to overcome C. glabrata fluconazole-resistance (MIC 32–64 µg mL−1).
Citations
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Authors (8)
-
Agnieszka Chylewska
-
Aleksandra M. Dąbrowska
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.1038/s41598-024-54252-0
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Scientific Reports
no. 14,
ISSN: 2045-2322 - Language:
- English
- Publication year:
- 2024
- Bibliographic description:
- Rząd K., Gabriel I., Paluszkiewicz E., Kuplińska A., Olszewski M., Chylewska A., Dąbrowska A. M., Kozłowska-Tylingo K.: Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity// Scientific Reports -Vol. 14,iss. 1 (2024),
- DOI:
- Digital Object Identifier (open in new tab) 10.1038/s41598-024-54252-0
- Sources of funding:
-
- IDUB
- Verified by:
- Gdańsk University of Technology
seen 23 times
Recommended for you
Enzymes of the lysine biosynthetic pathway as targets for antifungals ?
- I. Gabriel,
- P. Szweda,
- K. Kur
- + 3 authors
Xanthone synthetic derivatives with high anticandidal activity and positive mycostatic selectivity index values
- K. Rząd,
- R. Ioannidi,
- P. Marakos
- + 4 authors